Brian Mehling, M.D. – the Founder and Chief Medical Officer of Blue Horizon International (BHI), answers questions on Stem Cells in Regenerative Medicine
Read More
Happy Nurses Week
HAPPY NURSES WEEK! The theme for National Nurses Week in 2020 is Compassion|Expertise|Trust. National Nurses Week is celebrated annually from May 6, also known as National Nurses Day, through May 12, the birthday of Florence Nightingale, the founder of modern nursing. This week is devoted to highlighting the diverse ways in which registered nurses work to improve health care. We have never been able to repay nurses for all the work they do. For how thankful we’ll always be, nothing can repay the sacrifices they make in supporting doctors, consoling families, and being friends...
Read MoreBrian Mehling, MD participates in 9th Annual Brain Mapping Day
Brian Mehling, MD participated in the 9th Annual Brain Mapping Day: A joint Congressional briefing with the Society for Brain Mapping and Therapeutics, Brain Mapping Foundation, and the Congressional Neuroscience Caucus yesterday in Washington DC. The topic of Dr. Mehling’s presentation was “Safety and Efficacy of Stem Cell Therapy in Clinical Applications.” The materials presented focused on educating lawmakers about new technologies and innovations in the field of neuroscience, including stem cell therapy, enabling policies that are aligned with advancements made in...
Read MoreBHI Therapeutic Sciences Jamaica celebrates one year anniversary
A little more than one year ago, BHI Therapeutic Sciences Jamaica (BHI Jamaica), located in Montego Bay opened its doors and welcomed its first stem cell therapy patients. Since then, more than 50 patients have participated in investigational stem cell research. Brian Mehling, MD said: “Cellular medicine is in high demand and stem cells are being studied for a wide range of conditions. Stem cells are essentially “blank slate” cells that possess the remarkable potential to differentiate to any one of the billions of cells that form the diverse tissues of the human body....
Read MoreBrian Mehling, MD, (R) and Dongecheng Wu, MD, Ph.D., (L) during the stem cell applications at BHI Jamaica.
Dr. Mehling is the founder and chief medical officer of Mehling Orthopedics and BHI Therapeutic Sciences (BHITS). He is a practicing American orthopedic trauma surgeon, researcher, and philanthropist. He is also spearheading groundbreaking research in stem cell therapy. Notably, BHITS is currently engaged in an FDA Investigational New Drug trial for stroke, using human umbilical cord blood (hUCB) stem cells. Completing his degree of medicine at Wright State University School of Medicine, Dr. Mehling received post graduate education through residencies and fellowships at St....
Read MoreStem Cells Quality Reports
BHI Therapeutic Sciences supports investigational research and education in stem cell and regenerative medicine using cord blood cells. Its stem cell products evaluated in clinical studies are collected in accordance with Good Tissue Practice to ensure safety. The studies have been conducted following approval by an Investigational Research Board and in accordance with Good Clinical Practice. Its cellular products are investigational and have not been shown to be safe or effective for any disease or condition.Multiple studies of umbilical cord blood derived stem cell research...
Read More
